WOODWARD DAVID F,HEIDELBAUGH TODD M,STAMER W DANIEL
申请号：
IN8536/DELNP/2013
公开号：
IN2013DN08536A
申请日:
2013.10.01
申请国别(地区):
IN
年份:
2016
代理人:
摘要：
The invention provides compositions and methods for further reducing IOP in a subject who has already achieved maximal IOP reduction using known IOP lowering agents. The activity of an ocular hypotensive treatment regimen may be increased by adding an S1P antagonist to prevent S1P mediated reversal as a result of decreased aqueous humor outflow.
